Alzheimer's Disease And Dementia
In patients with mild Alzheimer's disease, solanezumab did not significantly reduce cognitive decline over time.
Positive beliefs about age may protect against dementia.
Depressive symptoms and apathy were independently associated with incident dementia in community-dwelling older adults.
In the United States, it is estimated that 15 million people will have clinical Alzheimer disease or mild cognitive impairment by 2060.
There is no significant risk of Alzheimer's disease or dementia for men getting androgen deprivation therapy.
Primary hyperparathyroidism may be linked to lower intracerebral vasomotor reactivity, which could lead to cognitive dysfunction.
Depressive symptoms and subjective memory complaint could be used as early detection markers of Alzheimer's disease.
Midlife vascular risk factors such as smoking, diabetes, and hypertension are linked to a higher risk for dementia.
People born in higher stroke mortality states seem to have more health issues including a higher risk of developing dementia.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Sertraline Effective for Treating Depression in Vascular Cognitive Impairment
- Hospitalization Rates in Schizophrenia—Lurasidone vs Quetiapine
- Ketamine-Induced Dissociative Symptoms Predict Antidepressant Response
- First Nonopioid Drug Approved for Managing Opioid Withdrawal Symptoms
- Review Examines the Effectiveness of Antidepressants for Insomnia
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- Comorbid Autism Spectrum Disorder and OCD: Challenges in Diagnosis and Treatment
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- Antidepressant Use May Be Linked With Sustained Risk for Weight Gain
- Language Used in Medical Record Can Affect Patient Care
- Family History of Psychiatric Disorders an Important Predictor of Postpartum Psychiatric Illness
- Increased Risk for Type 2 Diabetes in Adolescents, Young Adults With ADHD
- Worse Cognitive Outcomes Associated With CMV Antibodies Following ART for HIV